Clinical trials

6

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluate the Continued Safety and Performance of the Foot and Ankle Products

The objective of the registry is to evaluate the continued safety and performance of Arthrex foot and ankle products, including the ProStop® implant for hyperpronated foot; Bio-Compression Screw for reconstruction surgeries of the foot; TRIM-IT Drill Pin® system and/or TRIM-IT Spin Pin™ system for fixation of fractures and fusion (bunionectomy osteotomies) of the foot/ankle; Headless Compression Screws and Compression FT Screws for fixation of small bone fragments of the foot/ankle; DynaNite® nitinol staple for midfoot and hindfoot arthrodeses or osteotomies, first metatarsophalangeal arthrodesis, and mono or bi-cortical osteotomies in the forefoot; BioComposite SutureTak® anchor for medial ankle stabilization; Beveled FT Screws for hallux valgus repair; KreuLock™ screws for ankle fractures; ArthroFLEX® dermal allograft for hallux rigidus arthroplasty; and DualCompression Hindfoot Nail for tibiotalocalcaneal arthrodesis.

Participants needed: 700
Trial details
Age: 2+Biological sex: AllType: ObservationalSponsor: Arthrex, Inc.Updated: Feb 11, 2026Locations: 7Duration: 24 Months
Eligibility criteria

Subject requires surgery using Arthrex foot and ankle products included in the r... [+9]

Insufficient quantity or quality of bone. [+19]

Status: Recruiting

Total Shoulder Arthroplasty Multi-Center Registry

The objective of the study is a multi-center prospective registry to collect clinical outcomes of anatomic and reverse total shoulder arthroplasty.

Participants needed: 2,500
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Arthrex, Inc.Updated: Aug 11, 2025Locations: 24Duration: 10 Years
Eligibility criteria

Patient voluntarily consents to participate in the study and has the mental and... [+3]

Status: Recruiting

Registry of Arthrex Hand and Wrist Products

A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Effectiveness of Hand and Wrist Products

Participants needed: 650
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Arthrex, Inc.Updated: Jun 26, 2025Locations: 5Duration: 12 Months
Eligibility criteria

Subject requires surgery using Arthrex hand and wrist implants included in the r... [+3]

Insufficient quantity or quality of bone. [+5]

Status: Recruiting

Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears

The purpose of this study is to compare postoperative healing of large and massive rotator cuff tears with preoperative MRI confirmed fatty infiltration stage II and higher repaired with or without dermal allograft augmentation (DAA).

Participants needed: 120
Trial details
Age: 30-75Biological sex: AllType: ObservationalSponsor: Arthrex, Inc.Updated: Feb 24, 2025Locations: 4
Eligibility criteria

The subject is between the ages of 30 and 75 years. [+4]

The Subject is unable or unwilling to sign the patient informed consent, approve... [+11]

Status: Not yet recruiting

Nanoscope Cost Analysis Study

The study is a pilot study designed to generate preliminary data regarding the cost of partial meniscectomy using NanoScope versus conventional arthroscopy in a traditional operating room (OR) setting

Participants needed: 10
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: Arthrex, Inc.Updated: Sep 19, 2024Locations: 1
Eligibility criteria

Subject requires simple partial posterior or mid-body meniscectomy. [+5]

Subject requires complex repair or anterior meniscectomy. [+15]

Status: Recruiting

Knee Related Subchondral Bone Lesions Treated With IOBP

The study will be a prospective, multicenter clinical study evaluating clinical and patient reported outcome measures of subjects receiving IOBP® surgical technique using Angel cPRP and BMA processing system to treat subchondral bone pathology (SBP).

Participants needed: 100
Trial details
Age: 18-60Biological sex: AllType: ObservationalSponsor: Arthrex, Inc.Updated: Dec 5, 2022Locations: 5
Eligibility criteria

Able to read, understand, sign and complete informed consent [+7]

Subject has diabetes Type I, Type II uncontrolled, or Type II insulin dependent [+19]